11 Application of Accelerators and Storage Rings
789
51. J.S. Fowler, T. Ido, Initial and subsequent approach for the synthesis of 18FDG, Semin Nucl
Med. 32(1) (2002) 6-12
52. D. B. Mackay, C. J. Steel, K. Poole, S. McKnight, F. Schmitz, M. Ghyoot, R. Verbruggen,
F. Vamecq and Y. Jongen, Quality assurance for PET gas production using the Cyclone 3D
oxygen-15 generator, Applied Radiation and Isotopes, Volume 51, Issue 4 (1999) 403-409
53. IAEA-DCRP/2006, Directory of Cyclotrons used for Radionuclide Production in Member
States - 2006 Update, October 2006
54. N. Ramamoorthy, Production of radioisotopes for medical applications, Oral presentation,
Workshop Physics For Health in Europe, 2-4 February 2010, CERN, Geneva
55. G.O. Hendry et al., “Design and Performance of a H-Cyclotron,” Proc. of the 9th Int.
Conference on Cyclotrons and their Applications (1981) 125.
56. P. W. Schmor, Review of cyclotrons used in the production of radioisotopes for biomedical
applications, Proceedings of CYCLOTRONS 2010, Lanzhou, China
57. C. Oliver, Compact and efficient accelerators for radioisotope production, IPAC2017 -
Proceedings, June 2017, ISBN 978-3-95450-182-3
58. R. E. Shefer, R. E. Klinkowstein, M. J. Welch and J. W. Brodack, The Production of
Short Lived PET Isotopes at Low Bombarding Energy with a High Current Electrostatic
Accelerator. Proc. Third Workshop on Targetry and Target Chemistry, T. J. Ruth, ed.,
Vancouver, B.C., (1989)
59. A.R. Jalilian, J.A. Osso, Production, applications and status of zirconium-89 immunoPET
agents, J Radioanal Nucl Chem (2017) 314: 7. https://doi.org/10.1007
60. IAEA, Cyclotron Produced Radionuclides: Principles and Practice, Technical Reports Series
No. 465, International Atomic Energy Agency, Vienna, 2008
61. Therapeutic Nuclear Medicine, Richard P Baum, (Ed.), Springer-Verlag Berlin Heidelberg,
2014, ISBN 978-3-540-36719-2. DOI https://doi.org/10.1007/978-3-540-36719-2
62. Making Medical Isotopes, Report of the Task Force on Alternatives for Medical-Isotope
Production, TRIUMF University of British Columbia Advanced Applied Physics Solutions,
Inc. (2008)
63. Molybdenum-99 for Medical Imaging, The National Academies Press, Washington, DC,
ISBN 978-0-309-44531-3, DOI 10.17226/23563
64. IAEA, Non-HEU production technologies for molybdenum-99 and technetium-99m, Nuclear
Energy Series No. NF-T-5.4, Vienna: IAEA, 2013, ISBN 978–92–0–137710–4
65. W. K. H. Panofsky, Big Physics and Small Physics at Stanford, Stanford Historical Society,
Sandstone and Tile, Volume 14, no. 3 (1990) 1-10
66. D.W. Fry, R.B.R.S. Harvie, L.B Mullett, W. Walkinshaw, Travelling-wave linear accelerator
for electrons, Nature 160 (1947) 351-353
67. IAEA, DIrectory of RAdiotherapy Centres https://dirac.iaea.org/Query/Countries, as of 30
November 2017 [25] http://iopscience.iop.org/article/10.1088/1361-6560/aa9517
68. B W Raaymakers et al. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept
of a high-precision, high-field MRI guided radiotherapy treatment, Phys. Med. Biol. (2017)
62 L41
69. G. L. Locher, Biological effects and therapeutic possibilities of neutrons, Am. J. Roentgenol.
36, (1936) 1-13.
70. R.S. Stone, Neutron therapy and specific ionization, Am. J. Roentgenol. 59 (1948) 771-785
71. M. Awschalom, et al. The Fermilab Neutron Radiotherapy Facility, 1977 PAC, Chicago, IEEE
Trans. Nuc. Sci., Vol. NS-24, No. 3, (1977) 1055.
72. R.R. Wilson, Radiological use of fast protons, Radiobiology 47, (1946) 487-491
73. R.P. Levy, J.I. Fabrikant, K.A. Frankel, M.H. Phillips, J.T. Lyman, J.H. Lawrence, C.A.
Tobias, Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840
patients, Stereotact. Funct. Neurosurg. 57 (1-2), (1991) 22-35
74. C. A. Tobias, J. H. Lawrence, J. L. Born, R. K. Mccombs, J. E. Roberts, H. O. Anger, B. V.
A. Low-Beer, and C. B. Huggins, Pituitary Irradiation with High-Energy Proton Beams - A
Preliminary Report, Cancer Research 18, No 2, (1958) 121
789
51. J.S. Fowler, T. Ido, Initial and subsequent approach for the synthesis of 18FDG, Semin Nucl
Med. 32(1) (2002) 6-12
52. D. B. Mackay, C. J. Steel, K. Poole, S. McKnight, F. Schmitz, M. Ghyoot, R. Verbruggen,
F. Vamecq and Y. Jongen, Quality assurance for PET gas production using the Cyclone 3D
oxygen-15 generator, Applied Radiation and Isotopes, Volume 51, Issue 4 (1999) 403-409
53. IAEA-DCRP/2006, Directory of Cyclotrons used for Radionuclide Production in Member
States - 2006 Update, October 2006
54. N. Ramamoorthy, Production of radioisotopes for medical applications, Oral presentation,
Workshop Physics For Health in Europe, 2-4 February 2010, CERN, Geneva
55. G.O. Hendry et al., “Design and Performance of a H-Cyclotron,” Proc. of the 9th Int.
Conference on Cyclotrons and their Applications (1981) 125.
56. P. W. Schmor, Review of cyclotrons used in the production of radioisotopes for biomedical
applications, Proceedings of CYCLOTRONS 2010, Lanzhou, China
57. C. Oliver, Compact and efficient accelerators for radioisotope production, IPAC2017 -
Proceedings, June 2017, ISBN 978-3-95450-182-3
58. R. E. Shefer, R. E. Klinkowstein, M. J. Welch and J. W. Brodack, The Production of
Short Lived PET Isotopes at Low Bombarding Energy with a High Current Electrostatic
Accelerator. Proc. Third Workshop on Targetry and Target Chemistry, T. J. Ruth, ed.,
Vancouver, B.C., (1989)
59. A.R. Jalilian, J.A. Osso, Production, applications and status of zirconium-89 immunoPET
agents, J Radioanal Nucl Chem (2017) 314: 7. https://doi.org/10.1007
60. IAEA, Cyclotron Produced Radionuclides: Principles and Practice, Technical Reports Series
No. 465, International Atomic Energy Agency, Vienna, 2008
61. Therapeutic Nuclear Medicine, Richard P Baum, (Ed.), Springer-Verlag Berlin Heidelberg,
2014, ISBN 978-3-540-36719-2. DOI https://doi.org/10.1007/978-3-540-36719-2
62. Making Medical Isotopes, Report of the Task Force on Alternatives for Medical-Isotope
Production, TRIUMF University of British Columbia Advanced Applied Physics Solutions,
Inc. (2008)
63. Molybdenum-99 for Medical Imaging, The National Academies Press, Washington, DC,
ISBN 978-0-309-44531-3, DOI 10.17226/23563
64. IAEA, Non-HEU production technologies for molybdenum-99 and technetium-99m, Nuclear
Energy Series No. NF-T-5.4, Vienna: IAEA, 2013, ISBN 978–92–0–137710–4
65. W. K. H. Panofsky, Big Physics and Small Physics at Stanford, Stanford Historical Society,
Sandstone and Tile, Volume 14, no. 3 (1990) 1-10
66. D.W. Fry, R.B.R.S. Harvie, L.B Mullett, W. Walkinshaw, Travelling-wave linear accelerator
for electrons, Nature 160 (1947) 351-353
67. IAEA, DIrectory of RAdiotherapy Centres https://dirac.iaea.org/Query/Countries, as of 30
November 2017 [25] http://iopscience.iop.org/article/10.1088/1361-6560/aa9517
68. B W Raaymakers et al. First patients treated with a 1.5 T MRI-Linac: clinical proof of concept
of a high-precision, high-field MRI guided radiotherapy treatment, Phys. Med. Biol. (2017)
62 L41
69. G. L. Locher, Biological effects and therapeutic possibilities of neutrons, Am. J. Roentgenol.
36, (1936) 1-13.
70. R.S. Stone, Neutron therapy and specific ionization, Am. J. Roentgenol. 59 (1948) 771-785
71. M. Awschalom, et al. The Fermilab Neutron Radiotherapy Facility, 1977 PAC, Chicago, IEEE
Trans. Nuc. Sci., Vol. NS-24, No. 3, (1977) 1055.
72. R.R. Wilson, Radiological use of fast protons, Radiobiology 47, (1946) 487-491
73. R.P. Levy, J.I. Fabrikant, K.A. Frankel, M.H. Phillips, J.T. Lyman, J.H. Lawrence, C.A.
Tobias, Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840
patients, Stereotact. Funct. Neurosurg. 57 (1-2), (1991) 22-35
74. C. A. Tobias, J. H. Lawrence, J. L. Born, R. K. Mccombs, J. E. Roberts, H. O. Anger, B. V.
A. Low-Beer, and C. B. Huggins, Pituitary Irradiation with High-Energy Proton Beams - A
Preliminary Report, Cancer Research 18, No 2, (1958) 121